Mycoplasma hyorhinis activates the NLRP3 inflammasome and promotes migration and invasion of gastric chancer cells

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Xu, Yongfen ^a   Li, Hua ^a   Chen, Wei ^a   Yao, Xiaomin ^a   Xing, Yue ^a   Wang, Xun ^b   Zhong, Jin ^a   Meng, Guangxun ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b Shanghai Blood Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CRYOPYRIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IL 18 GENE; IL 1BETA GENE; IN VIVO STUDY; MACROPHAGE; METASTASIS; MONOCYTE; MOUSE; MYCOPLASMA HYORHINIS; NLRP3 GENE; NONHUMAN; POTASSIUM TRANSPORT; PROTEIN INDUCTION; STOMACH CANCER; TUMOR PROMOTION;

ANIMALS; BACTERIAL PROTEINS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; DENDRITIC CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMASOMES; INTERLEUKIN-18; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYCOPLASMA HYORHINIS; MYCOPLASMA INFECTIONS; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS;

EID: 84892428934     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077955     Document Type: Article

References (62)

1. Lo SC (1992) Mycoplasmas: molecular biology and pathogenesis. In: Maniloff J, McElheney RN, Finch LR, Baseman JB, editors. Am. Soc. Microbiol.Press, Washington, DC. p. 525-45.
2. Waites KB, Taylor-Robinson D (1999) Mycoplasma and ureaplasma. In:Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. Chap. 56, Am Soc Microbiol Press, Washington, DC.
3. Kobisch M, Friis NF (1996) Swine mycoplasmoses. Rev Sci Tech 15: 1569-1605.
4. Noelle RJ, Marshall L, Roy M, Shepherd DM, Stamenkovic I, et al. (1992) Role of contact and soluble factors in the growth and differentiation of B cells by helper T cells. Immune-Mediated Diseases: From Theory to Therapy 323: 131-138.
5. Huang S, Li JY, Wu J, Meng L, Shou CC (2001) Mycoplasma infections and different human carcinomas. World J Gastroenterol 7: 266-269.
6. Urbanek C, Goodison S, Chang M, Porvasnik S, Sakamoto N, et al. (2011) Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer. BMC Cancer 11: 233.
7. Schroder K, Tschopp J (2010) The inflammasomes. Cell 140: 821-832.
8. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, et al. (2011) Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12: 222-230.
9. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, et al. (2012) Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36: 401-414.
10. Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225.
11. Lee GS, Subramanian N, Kim AI, Aksentijevich I, Goldbach-Mansky R, et al. (2012) The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492: 123-127.
12. Murakami T, Ockinger J, Yu J, Byles V, McColl A, et al. (2012) Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A 109: 11282-11287.
13. Rossol M, Pierer M, Raulien N, Quandt D, Meusch U, et al. (2012) Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nat Commun 3: 1329.
14. van Deventer HW, Burgents JE, Wu QP, Woodford RM, Brickey WJ, et al. (2010) The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells. Cancer Res 70: 10161-10169.
15. Chow MT, Tschopp J, Moller A, Smyth MJ (2012) NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesothelioma. Immunol Cell Biol.
16. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, et al. (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15: 1170-1178.
17. Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, et al. (2010) The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 207: 1045-1056.
18. Dinarello CA (2010) Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev 29: 317-329.
19. Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, et al. (2008) Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14: 408-419.
20. Coughlin CM, Salhany KE, Wysocka M, Aruga E, Kurzawa H, et al. (1998) Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 101: 1441-1452.
21. Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, et al. (2000) Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Cancer Res 60: 4838-4844.
22. Lebel-Binay S, Berger A, Zinzindohoue F, Cugnenc P, Thiounn N, et al. (2000) Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw 11: 15-26.
23. Chandrasekar B, Mummidi S, Mahimainathan L, Patel DN, Bailey SR, et al. (2006) Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase- 9 expression and is inhibited by atorvastatin. J Biol Chem 281: 15099-15109.
24. Zhang B, Wu KF, Cao ZY, Rao Q, Ma XT, et al. (2004) IL-18 increases invasiveness of HL-60 myeloid leukemia cells: up-regulation of matrix metalloproteinases-9 (MMP-9) expression. Leuk Res 28: 91-95.
25. Thong-Ngam D, Tangkijvanich P, Lerknimitr R, Mahachai V, Theamboonlers A, et al. (2006) Diagnostic role of serum interleukin-18 in gastric cancer patients. World J Gastroenterol 12: 4473-4477.
26. Kang JS, Bae SY, Kim HR, Kim YS, Kim DJ, et al. (2009) Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44. Carcinogenesis 30: 1987-1996.
27. Kim KE, Song H, Kim TS, Yoon D, Kim CW, et al. (2007) Interleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines. Oncogene 26: 1468-1476.
28. Osawa R, Williams KL, Singh N (2011) The inflammasome regulatory pathway and infections: role in pathophysiology and clinical implications. J Infect 62: 119-129.
29. Yang J, Hooper WC, Phillips DJ, Talkington DF (2003) Interleukin-1beta responses to Mycoplasma pneumoniae infection are cell-type specific. Microb Pathog 34: 17-25.
30. Gong M, Meng L, Jiang B, Zhang J, Yang H, et al. (2008) p37 from Mycoplasma hyorhinis promotes cancer cell invasiveness and metastasis through activation of MMP-2 and followed by phosphorylation of EGFR. Mol Cancer Ther 7: 530-537.
31. Ketcham CM, Anai S, Reutzel R, Sheng S, Schuster SM, et al. (2005) p37 Induces tumor invasiveness. Mol Cancer Ther 4: 1031-1038.
32. Rottem S (2003) Interaction of mycoplasmas with host cells. Physiol Rev 83: 417-432.
33. Rawadi G, Roman-Roman S (1996) Mycoplasma membrane lipoproteins induced proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect Immun 64: 637-643.
34. He J, You X, Zeng Y, Yu M, Zuo L, et al. (2009) Mycoplasma genitaliumderived lipid-associated membrane proteins activate NF-kappaB through tolllike receptors 1, 2, and 6 and CD14 in a MyD88-dependent pathway. Clin Vaccine Immunol 16: 1750-1757.
35. Salazar JC, Duhnam-Ems S, La Vake C, Cruz AR, Moore MW, et al. (2009) Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta. PLoS Pathog 5: e1000444.
36. Meng G, Rutz M, Schiemann M, Metzger J, Grabiec A, et al. (2004) Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J Clin Invest 113: 1473-1481.
37. Lamkanfi M, Mueller JL, Vitari AC, Misaghi S, Fedorova A, et al. (2009) Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 187: 61-70.
38. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES (2009) AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458: 509-513.
39. Ha SD, Martins A, Khazaie K, Han J, Chan BM, et al. (2008) Cathepsin B is involved in the trafficking of TNF-alpha-containing vesicles to the plasma membrane in macrophages. Journal of Immunology 181: 690-697.
40. Bauernfeind F, Bartok E, Rieger A, Franchi L, Nunez G, et al. (2011) Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. Journal of Immunology 187: 613-617.
41. Yang H, Qu L, Ma H, Chen L, Liu W, et al. (2010) Mycoplasma hyorhinis infection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells. BMC Gastroenterol 10: 132.
42. Namiki K, Goodison S, Porvasnik S, Allan RW, Iczkowski KA, et al. (2009) Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells. PLoS One 4: e6872.
43. Roberts ED, Switzer WP, L'Ecuyer C (1962) Influence of Pasteurella multocida and Mycoplasma hyorhinis (PPLO) on the histopathology of field case of swine pneumonia. Cornell Vet 52: 306-327.
44. Liu W, Ren T, Jiang B, Gong M, Shou C (2007) Mycoplasmal membrane protein p37 promotes malignant changes in mammalian cells. Can J Microbiol 53: 270-276.
45. Kaler P, Augenlicht L, Klampfer L (2009) Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene 28: 3892-3902.
46. Khare S, Dorfleutner A, Bryan NB, Yun C, Radian AD, et al. (2012) An NLRP7-Containing Inflammasome Mediates Recognition of Microbial Lipopeptides in Human Macrophages. Immunity 36: 464-476.
47. Martinon F (2010) Signaling by ROS drives inflammasome activation. Eur J Immunol 40: 616-619.
48. Istivan TS, Coloe PJ (2006) Phospholipase A in Gram-negative bacteria and its role in pathogenesis. Microbiology 152: 1263-1274.
49. Kornspan JD, Rottem S (2012) Phospholipase A and glycerophosphodiesterase activities in the cell membrane of Mycoplasma hyorhinis. FEMS Microbiol Lett.
50. Feng SH, Tsai S, Rodriguez J, Lo SC (1999) Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Mol Cell Biol 19: 7995-8002.
51. Tsai S, Wear DJ, Shih JW, Lo SC (1995) Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. Proc Natl Acad Sci U S A 92: 10197-10201.
52. Yamanaka N, Morisaki T, Nakashima H, Tasaki A, Kubo M, et al. (2004) Interleukin 1beta enhances invasive ability of gastric carcinoma through nuclear factor-kappaB activation. Clin Cancer Res 10: 1853-1859.
53. Hernandez L, Smirnova T, Wyckoff J, Condeelis J, Segall JE (2009) In vivo assay for tumor cell invasion. Methods Mol Biol 571: 227-238.
54. Sung H, Kang SH, Bae YJ, Hong JT, Chung YB, et al. (2006) PCR-based detection of Mycoplasma species. J Microbiol 44: 42-49.
55. Rawadi G, Ramez V, Lemercier B, Roman-Roman S (1998) Activation of mitogen-activated protein kinase pathways by Mycoplasma fermentans membrane lipoproteins in murine macrophages: involvement in cytokine synthesis. Journal of Immunology 160: 1330-1339.
56. Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, et al. (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14: 1583-1589.
57. Fernandes-Alnemri T, Alnemri ES (2008) Assembly, purification, and assay of the activity of the ASC pyroptosome. Methods Enzymol 442: 251-270.
58. Bao M, Chen Z, Xu Y, Zhao Y, Zha R, et al. (2012) Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma. Liver Int 32: 331-338.
59. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, et al. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218.
60. Meng G, Zhang F, Fuss I, Kitani A, Strober W (2009) A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 30: 860-874.
61. Mao K, Chen S, Chen M, Ma Y, Wang Y, et al. (2013) Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock. Cell Res 23: 201-212.
62. Lei G, Chen M, Li H, Niu JL, Wu S, et al. (2013) Biofilm from a clinical strain of Cryptococcus neoformans activates the NLRP3 inflammasome. Cell Res.